rs201139273
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP2
The NM_001244008.2(KIF1A):c.4771C>T(p.Arg1591Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000125 in 1,611,406 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1591Q) has been classified as Likely benign.
Frequency
Consequence
NM_001244008.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KIF1A | NM_001244008.2 | c.4771C>T | p.Arg1591Trp | missense_variant | 45/49 | ENST00000498729.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KIF1A | ENST00000498729.9 | c.4771C>T | p.Arg1591Trp | missense_variant | 45/49 | 5 | NM_001244008.2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000148 AC: 36AN: 243746Hom.: 0 AF XY: 0.000165 AC XY: 22AN XY: 132938
GnomAD4 exome AF: 0.000122 AC: 178AN: 1459080Hom.: 1 Cov.: 31 AF XY: 0.000121 AC XY: 88AN XY: 725638
GnomAD4 genome AF: 0.000158 AC: 24AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74482
ClinVar
Submissions by phenotype
not provided Uncertain:6
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jan 05, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | KIF1A: PM2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 22, 2023 | Observed with another variant on the opposite allele (in trans) in a patient with seizures, optic nerve atrophy, and hypotonia; however, spasticity and neuropathy were not reported (PMID: 33880452); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33880452) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 09, 2017 | - - |
Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Sep 17, 2021 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2022 | The p.R1591W variant (also known as c.4771C>T), located in coding exon 44 of the KIF1A gene, results from a C to T substitution at nucleotide position 4771. The arginine at codon 1591 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. - |
Hereditary spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Apr 22, 2021 | - - |
KIF1A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 20, 2023 | The KIF1A c.4771C>T variant is predicted to result in the amino acid substitution p.Arg1591Trp. This variant was reported in the compound heterozygous state in a patient with seizures, optic nerve atrophy and hypotonia (Patient K_011 in Table S1, Boyle et al. 2021. PubMed ID: 33880452). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.043% of alleles in individuals of Latino descent in gnomAD and has conflicting interpretations in ClinVar ranging from uncertain to likely benign (review.ncbi.nlm.nih.gov/clinvar/variation/377242/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at